The @US_FDA has begun to approve biosimilars for v

The @US_FDA has begun to approve biosimilars for vasculitis medications. And patients have questions. To help them… https://t.co/avcGrrkqU7

@HislopMD With all due respect, you are incorrect

@HislopMD With all due respect, you are incorrect on “leaky gut syndrome” the @The_GEMProject linked this to… https://t.co/7xL6riw2g4

Getting deeply personal and launching one of my Fractured series on @makersplaceco (ed of 5).
#NFTs #nftart… https://t.co/AUqroO3uOC

Have you joined the #IBDSuperHeroes Facebook group?⁠
⁠
1.9K wonderful #IBDWarriors – Great for chats, tips, rants &… https://t.co/8A80iBi0Dw

Daily Updates on Generic Entry, Litigation, Biosimilars, and more with the DrugPatentWatch Daily Briefing. Sign up… https://t.co/qlK9YzNTIA

You don’t even want to know what my Remicade costs to treat my Crohn’s disease. #IBD #crohns #crohnsdisease https://t.co/kc4Opdl6LJ

Crohns Disease drug Market Analysis, Regional Outlook, Competitive Strategies and Forecasts to …… https://t.co/KRsD2hgOFb

Crohns Disease Market Segmentation, Analysis by Recent Trends, Development & Growth by … https://t.co/dZubwW1hSm #crohns #crohnsdisease

At the #EAHPSynergy w/ S. Simoens Professor of health economics at the @LeuvenU analysing the financial impact of… https://t.co/aumouoL0q8

@unseenvalue Despite the largest number of approved #biosimilars in India, very few Indian companies have been able… https://t.co/Rd3bkkeGpu